| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |